Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Fonar Corp (FONR)
Fonar Corp (FONR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,412
  • Shares Outstanding, K 6,328
  • Annual Sales, $ 98,650 K
  • Annual Income, $ 9,380 K
  • 60-Month Beta 1.10
  • Price/Sales 1.44
  • Price/Cash Flow 8.05
  • Price/Book 0.92
Trade FONR with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.44 +19.55%
on 02/02/24
24.05 -3.37%
on 02/20/24
+3.56 (+18.09%)
since 01/26/24
3-Month
18.84 +23.35%
on 01/11/24
24.05 -3.37%
on 02/20/24
+3.74 (+19.18%)
since 11/24/23
52-Week
12.13 +91.59%
on 10/26/23
24.05 -3.37%
on 02/20/24
+6.19 (+36.30%)
since 02/24/23

Most Recent Stories

More News
Fonar: Fiscal Q2 Earnings Snapshot

Fonar: Fiscal Q2 Earnings Snapshot

FONR : 23.24 (+1.84%)
Fonar Announces Six Months and 2nd Quarter Financial Results for Fiscal 2024

Total MRI scan volume at the HMCA-managed sites increased 13% to 101,990 scans for the six months ending December 31, 2023 versus the corresponding period one year earlier. Cash and cash equivalents and...

FONR : 23.24 (+1.84%)
2024 Strategies: Buy or Hold for 3 Medical Stocks?

While the unceasing need for healthcare services, pharmaceuticals, and medical innovations underscores the resilience of the medical industry, let us analyze whether to Buy or Hold renowned medical stocks...

FONR : 23.24 (+1.84%)
LFVN : 6.98 (+3.71%)
WBA : 20.99 (-3.41%)
Holiday Outlook: 3 Medical Stocks to Consider Buying

The medical sector is expected to grow amid steady demand and technological advancements. Given the solid long-term prospects of the industry, fundamentally sound medical stocks Tenet Healthcare (THC),...

FONR : 23.24 (+1.84%)
SMLR : 48.51 (+2.47%)
THC : 91.81 (-1.07%)
Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook...

FONR : 23.24 (+1.84%)
HSIC : 80.57 (+0.89%)
MDXG : 8.26 (+0.73%)
OCPNY : 18.0000 (-1.37%)
Assessing Alcon Inc.’s (ALC) Post-Earnings Prospects: Is It Time to Invest, Hold, or Let Go?

Is Swiss eye care leader Alcon Inc. (ALC) a buy, hold, or sell after its third-quarter earnings release yesterday? Let’s look at its financial metrics to gauge its prospects… Geneva, Switzerland-based...

ALC : 80.53 (+0.59%)
FONR : 23.24 (+1.84%)
MDXG : 8.26 (+0.73%)
VREX : 17.28 (+0.41%)
Fonar: Fiscal Q1 Earnings Snapshot

Fonar: Fiscal Q1 Earnings Snapshot

FONR : 23.24 (+1.84%)
Fonar Announces Financial Results for the 1st Quarter of Fiscal 2024

On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. At September 30, 2023, the Company has purchased 146,359 shares at a cost of $2,473,215.Total MRI scan volume at...

FONR : 23.24 (+1.84%)
Becton Dickinson & Co. (BDX) Earnings Moves: A Buy or Sell for Investors?

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over...

BDX : 241.72 (-1.82%)
ELMD : 15.50 (+3.47%)
FONR : 23.24 (+1.84%)
MDXG : 8.26 (+0.73%)
Fonar Announces Distributor Agreement with AIRS Medical, Leader in AI-Powered MRI Technology

Melville, New York--(Newsfile Corp. - November 8, 2023) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announces that it is now the exclusive distributor of SwiftMR™ from AIRS Medical,...

FONR : 23.24 (+1.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients...

See More

Key Turning Points

3rd Resistance Point 24.11
2nd Resistance Point 23.68
1st Resistance Point 23.46
Last Price 23.24
1st Support Level 22.81
2nd Support Level 22.38
3rd Support Level 22.16

See More

52-Week High 24.05
Last Price 23.24
Fibonacci 61.8% 19.50
Fibonacci 50% 18.09
Fibonacci 38.2% 16.68
52-Week Low 12.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar